Quality of Care for Older Patients With Non-Cancer Diagnoses Under the End-of-Life Care Program
DOI:
https://doi.org/10.17140/PMHCOJ-2-111Keywords:
End of life, Elderly, Chronic diseases, Advanced care plan, Palliative careAbstract
Background: End-of-life (EOL) care is an important part of geriatric medicine in view of rap-idly ageing populations in the world.
Aim: We aimed to evaluate the quality of care for older patients with non-cancer terminal ill-nesses, who died in 2010, under the EOL care program of an academic medical unit in Hong Kong. This unit consisted of an acute hospital, Prince of Wales Hospital (PWH) and a convalescence hospital (Shatin Hospital, SH).
Methods: This was a retrospective hospital-based audit of clinical effectiveness of the EOL service. We reviewed the quality of patient care during the final seven days of life. The quality of care was evaluated based on the compliance rates of five selected goals and the adoption of futile life-sustaining procedures and treatments.
Results: Case records of 129 patients in the EOL care program were analyzed. Two goals, including minimization of regular monitoring of vital signs and no blood taking, achieved over 70% compliance at SH and 0% at PWH. The compliance rates of discontinuation of non-essen-tial medications were 46.4% in SH and 47.1% in PWH; and the compliance rates of switching essential medications to non-oral routes were 63.4% in SH and 70.6% in PWH (not statistically significant). The compliance rates of using as-required intravenous or subcutaneous medica-tions were extremely low (<2%) at both hospitals. All futile life-sustaining procedures and treatments were initiated at the PWH.
Conclusions: We demonstrated significant differences in the quality of EOL care between the acute hospital and convalescence hospital. Greater emphasis on specialist training and educa-tion with allocation of resources may improve the EOL care in both settings.
References
World Health Organization, Worldwide Palliative Care Alli-ance. Global atlas of palliative care at the end of life. Cancer. Available at: http://www.who.int/cancer/publications/palliative-care-atlas/en/ 2014; Accessed 2015.
Gardiner C, Cobb M, Gott M. Barriers to providing palliative care for older people in acute hospitals. Age and Aging. 2011; 40: 233-238. doi: 10.1093/ageing/afq172
Reynolds K, Henderson M, Schulman A, Hanson LC. Needs of the dying in nursing homes. J Palliat Med. 2002; 5(6): 895- 901. doi: 10.1089/10966210260499087
Luk JK, Liu A, Ng WC, Lui B, Beh P, Chan FH. End-of-life care: towards a more dignified dying process in residential care homes for the elderly. Hong Kong Med J. 2010; 16(3): 235-236.
Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med. 2009; 361(16): 1529-1538. doi: 10.1056/NEJMoa0902234
World Health Organization Cancer Program. Definition of palliative care. Available at: http://www.who.int/cancer/pallia-tive/definition/en/ 2015; Accessed July 8, 2015.
Woo J. Quality of dying. In: Woo J, ed. Ageing in Hong Kong: a comparative perspective. New York, NY, USA; 2013: 235-256.
Tsim S, Davidson S. End-of-life care in a general respiratory ward in the United Kingdom. Am J Hosp Palliat Care. 2014; 31(2): 172-174. doi: 10.1177/1049909113481261
Siu WK, Liu KY, Cheung KW, et al. End-of-life-care for Chi-nese patients in acute care ward setting: experience in an on-cology ward and report on a pilot project on the use of an in-tegrated care pathway. Palliat Med. 2011; 25(6): 664-665. doi:
1177/0269216311407103 10. Woo J, Lo R, Cheng JO, Wong F, Mak B. Quality of end-of-life care for non-cancer patients in a non-acute hospital. J Clin Nurs. 2011; 20: 1834-1841. doi: 10.1111/j.1365-2702.2010.03673.x
Connors AF, Dawson NV, Desbiens NA, et al. A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA.1995; 274(20): 1591- 1598. doi: 10.1001/jama.1995.03530200027032
Biola H, Sloane PD, Williams CS, Daaleman TP, Zimmer-man S. Preferences versus practice: life-sustaining treatments in last months of life in long term care. J Am Med Dir Assoc. 2010; 11(1): 42-51. doi: 10.1016/j.jamda.2009.07.005
World Health Organization. Essential medicines in pal-liative care: executive summary. Website: http://www.who. int/selection_medicines/committees/expert/19/applications/ PalliativeCare_8_A_R.pdf 2013; Accessed July 8, 2015.
Lo SH, Chan CY, Chan CH, et al. The implementation of an end-of-life integrated care pathway in a Chinese population. Int J Palliat Nurs. 2009; 15(8): 384-388.
Phillips JL, Halcomb EJ, Davidson PM. End-of-Life care pathways in acute and hospice care: an integrative review. J Pain Symptom Manage. 2011; 41: 940-955. doi: 10.1016/j.jpainsym-man.2010.07.020
McConnell T, O’Halloran P, Porter S, Donnelly M. System-atic realist review of key factors affecting the successful imple-mentation and sustainability of the liverpool care pathway for the dying patient. Worldviews Evid Based Nurs. 2013; 10(4): 218-237. doi: 10.1111/wvn.12003
Department of Health. Independent report review of liver-pool care pathway for dying patients. more care, less pathway: a review of the liverpool care pathway. Website: https://www. gov.uk/government/uploads/system/uploads/attachment_data/ file/212450/Liverpool_Care_Pathway.pdf 2013; Accessed July 8, 2015.
Samara J, Larkin D, Chan CW, Lopez V. Advance care plan-ning in the oncology settings. Int J Evid Based Healthc. 2013; 11(2): 110-114. doi: 10.1111/1744-1609.12011
Verhofstede R, Smets T, Cohen J, Costantini M, Noortgate NVD, Deliens L. Improving end-of-life care in acute geriatric hospital wards using the care program for the last days of life: study protocol for a phase 3 cluster randomized controlled trial. BMC Geriatrics. 2015; 15: 13. doi: 10.1186/s12877-015-0010-7
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Palliative Medicine and Hospice Care (PMHC) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
